Expression of galectin-3, nm-23, and cyclooxygenase-2 could potentially discriminate between benign and malignant pheochromocytoma.
暂无分享,去创建一个
R. Heshmat | B. Larijani | A. Rajabiani | H. Saffar | V. Haghpanah | S. Tavangar | S. Sanii | S. Azimi
[1] C. Fletcher,et al. Diagnostic histopathology of tumors , 2013 .
[2] S. Silverberg,et al. Silverberg's principles and practice of surgical pathology and cytopathology vol. 1 , 2013 .
[3] D. E. Mills,et al. Sternberg's Diagnostic Surgical Pathology , 2012 .
[4] R. Heshmat,et al. Immunohistochemical expression of Ki67, c-erbB-2, and c-kit antigens in benign and malignant pheochromocytoma. , 2010, Pathology, research and practice.
[5] A. Mansoor. Modern Surgical Pathology , 2010 .
[6] Xiang Li,et al. [The effects of nm23-H1 gene cell transfection on abilities of invasion, adhesion and chemotherapeutic sensitivity of bladder cancer T-24 cell line]. , 2007, Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition.
[7] M. Chou,et al. Prognostic significance of expression of nm23-H1 and focal adhesion kinase in non-small cell lung cancer. , 2007, Oncology reports.
[8] A. Popovtzer,et al. Cyclooxygenase‐2 expression in medullary thyroid carcinoma , 2007, Head & neck.
[9] G. Kayser,et al. The role of microvascularization and growth/adhesion-regulatory lectins in the prognosis of non-small cell lung cancer in stage II. , 2007, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[10] L. Habel,et al. NSAIDs and breast cancer recurrence in a prospective cohort study , 2007, Cancer Causes & Control.
[11] J. Ochieng,et al. Mechano-transduction mediated secretion and uptake of galectin-3 in breast carcinoma cells: implications in the extracellular functions of the lectin. , 2007, Experimental cell research.
[12] H. Dralle,et al. Distinct Expression of Galectin‐3 in Pheochromocytomas , 2006, Annals of the New York Academy of Sciences.
[13] Shailesh Singh,et al. Inhibition of cyclooxygenase-2 decreases breast cancer cell motility, invasion and matrix metalloproteinase expression , 2006, BMC Cancer.
[14] A. Renshaw. Silverberg??s Principles and Practice of Surgical Pathology and Cytopathology , 2006 .
[15] Yin Li,et al. [nm23-H1 gene inhibits lung cancer cell invasion through down-regulation of PKC signal pathway]. , 2006, Zhonghua zhong liu za zhi [Chinese journal of oncology].
[16] A. Lucci,et al. COX-2 induces IL-11 production in human breast cancer cells. , 2006, The Journal of surgical research.
[17] B. Ning,et al. Identification of functional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer. , 2005, Gastroenterology.
[18] B. Ning,et al. Identification of Functional Genetic Variants in and Their Association With Risk of Esophageal Cancer , 2005 .
[19] Y. Maehara,et al. Galectin-3 expression is a potent prognostic marker in colorectal cancer. , 2005, Anticancer research.
[20] K. Ohba,et al. Expression of nm23-H1 gene product in sarcomatous cancer cells of renal cell carcinoma: correlation with tumor stage and expression of matrix metalloproteinase-2, matrix metalloproteinase-9, sialyl Lewis X, and c-erbB-2. , 2005, Urology.
[21] A. Lucci,et al. COX-2 overexpression increases motility and invasion of breast cancer cells. , 2005 .
[22] K. Pacak,et al. Downregulation of metastasis suppressor genes in malignant pheochromocytoma , 2005, International journal of cancer.
[23] Yingjia Sun,et al. [Molecular mechanism of reversing metastatic phenotype in human high-metastatic large cell lung cancer cell line L9981 by nm23-H1]. , 2005, Ai zheng = Aizheng = Chinese journal of cancer.
[24] R. Lloyd,et al. Role of COX-2, thromboxane A2 synthase, and prostaglandin I2 synthase in papillary thyroid carcinoma growth , 2005, Modern Pathology.
[25] A. Piga,et al. Galectin-3 expression in non-small cell lung carcinoma. , 2004, Cancer letters.
[26] R. DuBois,et al. Cyclooxygenase as a Target in Lung Cancer , 2004, Clinical Cancer Research.
[27] Changyu Wang,et al. Association between Nm23-H1 gene expression and metastasis of ovarian carcinoma. , 2004, Ai zheng = Aizheng = Chinese journal of cancer.
[28] R. Kittles,et al. Delivery technique plays an important role in determining vessel wall apposition of the Enterprise self-expanding intracranial stent , 2011, Journal of Neurointerventional Surgery.
[29] P. Datta,et al. Expression profile of genes associated with antimetastatic gene: nm23‐Mediated metastasis inhibition in breast carcinoma cells , 2004, International journal of cancer.
[30] Yulian Wu,et al. [The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma]. , 2002, Zhonghua yi xue za zhi.
[31] L. Thompson. Pheochromocytoma of the Adrenal Gland Scaled Score (PASS) to Separate Benign From Malignant Neoplasms: A Clinicopathologic and Immunophenotypic Study of 100 Cases , 2002, The American journal of surgical pathology.
[32] P. Heikkilä,et al. Increased expression of cyclooxygenase-2 in malignant pheochromocytomas. , 2001, The Journal of clinical endocrinology and metabolism.
[33] N. Chow,et al. The role of nm23-H1 in the progression of transitional cell bladder cancer. , 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.
[34] F. Fitzpatrick,et al. Cyclooxygenase-2 and carcinogenesis. , 2000, Biochimica et biophysica acta.
[35] R. DeLellis,et al. Principles and Practice of Surgical Pathology and Cytopathology , 1999 .
[36] M. S. Lakshmi,et al. Expression of metastasis-associated genes h-mts1 (S100A4) and nm23 in carcinoma of breast is related to disease progression. , 1998, DNA and cell biology.
[37] G. Bevilacqua,et al. Down‐regulation of the nm23.h1 gene inhibits cell proliferation , 1997, International journal of cancer.
[38] R. Bast,et al. Expression of the 67-kD laminin receptor, galectin-1, and galectin-3 in advanced human uterine adenocarcinoma. , 1996, Human pathology.
[39] M J Bissell,et al. A Novel Function for the nm23-Hl Gene: Overexpression in Human Breast Carcinoma Cells Leads to the Formation of Basement Membrane and Growth Arrest , 2010 .
[40] H. Tashiro,et al. Expression of metastasis-related nm23-H1 and nm23-H2 genes in ovarian carcinomas: correlation with clinicopathology, EGFR, c-erbB-2, and c-erbB-3 genes, and sex steroid receptor expression. , 1994, Cancer research.
[41] DeAtkine Ab,et al. The adrenal glands. , 1991 .
[42] G. Cahill,et al. Tumors of the adrenal gland. , 1950, The Journal of urology.
[43] S. Suster,et al. Modern Surgical Pathology , 2009 .
[44] E. Lack. Tumors of the adrenal glands and extraadrenal paraganglia , 2007 .
[45] Shun-liang Gao,et al. Expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma. , 2005, World journal of gastroenterology.
[46] E. Bruyneel,et al. [Cyclooxygenase 2 and carcinogenesis]. , 2004, Bulletin du cancer.
[47] J. Sygut,et al. Usefulness of galectin-3 immunohistochemistry in differential diagnosis between thyroid follicular carcinoma and follicular adenoma. , 2003, Polish journal of pathology : official journal of the Polish Society of Pathologists.
[48] K. Kovacs,et al. An immunohistochemical survey of nine cases of medullary carcinoma of thyroid including reactivity for Cox-1 and Cox-2 enzymes , 2002, Endocrine pathology.
[49] Sevin. [Adrenal glands]. , 1959, Produits pharmaceutiques.
[50] F. Hartman,et al. The adrenal gland , 1949 .